LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP VEIN THROMBOSIS AFTER GYNAECOLOGICAL SURGERY

Abstract
Summary: The prophylactic effect of low doses of subcutaneous heparin in the prevention of deep vein thrombosis after major gynaecological surgery was investigated in a clinical trial involving 110 patients. Evidence of thrombosis was detected by the 1251‐labelled fibrinogen test in 16 out of 55 patients (29 per cent) in the control group, and in 2 out of 55 patients (3.6 per cent) in the heparin‐treated group. Only longevity had a significant association with the development of deep vein thrombosis.